RecruitingNCT07117058

Validation of a Rapid Screening Tool for Anxiety-depressive Disorders in Children, Adolescents and Young Adults Treated in Oncology. Multicenter Study.

Validation of a Rapid Screening Tool for Anxiety-depressive Disorders in Children, Adolescents and Young Adults Treated in Oncology. Multicenter Study. Short Title: HARMONY-Tool


Sponsor

Centre Hospitalier Universitaire de Saint Etienne

Enrollment

545 participants

Start Date

Mar 18, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

In France today, it is estimated that one in every 850 people aged between 20 and 45 is a childhood cancer survivor (CCS), equivalent to around 40,000 to 50,000 people. Some descriptive studies have established that the diagnosis and treatment of cancer can affect psychological health. A French study published by our team in 2015 and 2020 showed that in adulthood, 40% of CCS had anxiety symptoms, a rate significantly higher than that of the general French population (25%). However, although there are validated scales for screening children for psychological disorders (anxiety, depression, etc.), there is no rapid screening tool that can be used routinely by an oncologist during consultations. So, the study aims to develop and validate a short test, which could easily be carried out systematically during follow-up consultations after childhood cancer. It would make it possible to identify people with no psychological complications and, conversely, those in whom further investigation, based on the classic reference scales for assessing psychological disorders, would be relevant.


Eligibility

Min Age: 7 YearsMax Age: 25 Years

Inclusion Criteria5

  • Patients diagnosed with pediatric cancer before the age of 18,
  • Patient whose intensive treatment had ended at least 3 months prior to inclusion,
  • Patients considered to be in complete remission by the doctor responsible for their treatment,
  • Patient affiliated to or entitled under a social security scheme,
  • Patient having received informed information about the study OR the holder(s) of parental authority having received informed information about the study in the case of minors.

Exclusion Criteria5

  • Refusal to participate expressed by the patient or minor,
  • Patients whose cancer has relapsed or progressed,
  • Pregnant women, women in labor, breast-feeding mothers,
  • Persons deprived of their liberty, hospitalized without consent, hospitalized for purposes other than those of the research,
  • Adults under legal protection (guardianship) or unable to express their consent.

Interventions

DIAGNOSTIC_TESTNew rapid screening tool for anxiety and depressive disorders

New rapid screening tool for anxiety and depressive disorders completed by patient during a regular follow-up consultation

DIAGNOSTIC_TESTSCARED-R-51 (Screen for Child Anxiety Related Emotional Disorders-Revised)

Questionnaire completed by patient during a regular follow-up consultation : ONLY for patients 7-14 years old.

DIAGNOSTIC_TESTHADS (Hospital Anxiety and Depression Scale)

Questionnaire completed by patient during a regular follow-up consultation : ONLY for patients 15-25 years old.


Locations(5)

Centre Hospitalier Universitaire

Grenoble, France

IHOP

Lyon, France

Centre Hospitalier Universitaire

Rouen, France

CHU de Saint-Etienne

Saint-Etienne, France

Centre Hospitalier Universitaire

Tours, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07117058


Related Trials